Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZimmer Biomet

About this trial

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient is of legal age and skeletally mature

Patient is willing and able to provide written Informed Consent by signing and dating the Institutional Review Board (IRB) / Ethics Committee (EC) approved Informed Consent document

Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol

Independent of study participation, patient qualifies for either cemented or cementless primary or revision total knee arthroplasty (including salvage of previously failed surgical attempts) based upon physical exam and medical history, and meets the approved indications for use of the commercially available Persona Knee System with appropriately matched Zimmer Biomet components implanted in accordance with product labeling

Disqualifiers

Patient is currently participating in any other surgical intervention or pain management study

Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)

Patient has a mental or neurological condition who is unwilling or incapable of following postoperative care instructions

Patient has a condition which would, in the judgment of the investigator, place the patient at undue risk or interfere with the conduct of the study

Trial population

The study population will be a subset of the US population electing to proceed with total knee arthroplasty irrespective of participation in the study and: 1) who will be receiving one or more of the components of interest as part of standard clinical care, 2) agree to participate by completing a study-specific informed consent form, and 3) who satisfy the inclusion/exclusion criteria.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Total Knee Arthroplasty

    Device

    Total knee replacement.

Treatment groups

760 Participants
are divided into 12 treatment groups

12

Treatment groups

See each treatment group below.

Group A: Cohort 11 intervention
Group B: Cohort 21 intervention
Group C: Cohort 31 intervention
Group D: Cohort 41 intervention
Group E: Cohort 51 intervention
Group F: Cohort 61 intervention
Group G: Cohort 71 intervention
Group H: Cohort 81 intervention
Group I: Cohort 91 intervention
Group J: Cohort 101 intervention
Group K: Cohort 111 intervention
Group L: Cohort 121 intervention

Trial outcomes

Primary outcomes

1

Oxford Knee Score (OKS)

A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.

Time frame
5 years

Secondary outcomes

1

EuroQol Five Dimension Five Level (EQ-5D-5L) Outcomes Measure

A questionnaire completed by the patient and assesses his/her general health status. This score ranges from -0.573 to 1, with higher recorded scores indicating better overall health.

Time frame
5 years
2

Pain and Satisfaction Numeric Rating Scale (NRS)

Patients will rate their current pain intensity from 0 ("no pain") to 10 ("worst possible pain"). Along with their pain rating, subjects will be asked to rate their current satisfaction with their surgery from "Very Dissatisfied" to "Very Satisfied".

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.